annual SGA:
$3.70B+$204.00M(+5.83%)Summary
- As of today (May 29, 2025), TEVA annual SGA is $3.70 billion, with the most recent change of +$204.00 million (+5.83%) on December 31, 2024.
- During the last 3 years, TEVA annual SGA has risen by +$174.00 million (+4.93%).
- TEVA annual SGA is now -30.40% below its all-time high of $5.32 billion, reached on December 31, 2013.
Performance
TEVA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$919.00M-$33.00M(-3.47%)Summary
- As of today (May 29, 2025), TEVA quarterly SGA is $919.00 million, with the most recent change of -$33.00 million (-3.47%) on March 31, 2025.
- Over the past year, TEVA quarterly SGA has increased by +$33.00 million (+3.72%).
- TEVA quarterly SGA is now -36.53% below its all-time high of $1.45 billion, reached on December 31, 2013.
Performance
TEVA quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$59.61B-$1.28B(-2.20%)Summary
- As of today (May 29, 2025), TEVA TTM SGA is -$59.61 billion, with the most recent change of -$1.28 billion (-2.20%) on March 31, 2025.
- Over the past year, TEVA TTM SGA has dropped by -$63.15 billion (-1782.83%).
- TEVA TTM SGA is now -199.44% below its all-time high of $59.94 billion.
Performance
TEVA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
TEVA Selling, general & administrative expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +5.8% | +3.7% | -1782.8% |
3 y3 years | +4.9% | +4.4% | -1787.1% |
5 y5 years | -2.7% | +0.2% | -1675.2% |
TEVA Selling, general & administrative expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +7.5% | -3.5% | +11.8% | -38.5% | at low |
5 y | 5-year | -2.7% | +7.5% | -9.0% | +11.8% | -115.5% | at low |
alltime | all time | -30.4% | >+9999.0% | -36.5% | +1863.7% | -199.4% | at low |
TEVA Selling, general & administrative expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $919.00M(-3.5%) | $3.73B(+0.9%) |
Dec 2024 | $3.70B(+5.8%) | $952.00M(+3.0%) | $3.70B(+1.4%) |
Sep 2024 | - | $924.00M(-1.6%) | $3.65B(+2.2%) |
Jun 2024 | - | $939.00M(+6.0%) | $3.57B(+0.8%) |
Mar 2024 | - | $886.00M(-1.8%) | $3.54B(+1.3%) |
Dec 2023 | $3.50B(+1.5%) | $902.00M(+6.9%) | $3.50B(+1.9%) |
Sep 2023 | - | $844.00M(-7.3%) | $3.43B(+0.6%) |
Jun 2023 | - | $910.00M(+8.1%) | $3.41B(+0.1%) |
Mar 2023 | - | $842.00M(+0.6%) | $3.41B(-1.1%) |
Dec 2022 | $3.44B(-2.4%) | $837.00M(+1.8%) | $3.45B(-2.0%) |
Sep 2022 | - | $822.00M(-9.4%) | $3.52B(-1.8%) |
Jun 2022 | - | $907.00M(+3.1%) | $3.58B(+1.4%) |
Mar 2022 | - | $880.00M(-3.1%) | $3.53B(+0.1%) |
Dec 2021 | $3.53B(-3.9%) | $908.00M(+2.3%) | $3.53B(-2.8%) |
Sep 2021 | - | $888.00M(+3.6%) | $3.63B(+0.1%) |
Jun 2021 | - | $857.00M(-2.1%) | $3.63B(-0.1%) |
Mar 2021 | - | $875.00M(-13.4%) | $3.63B(-1.1%) |
Dec 2020 | $3.67B(-3.5%) | $1.01B(+14.3%) | $3.67B(-0.4%) |
Sep 2020 | - | $884.00M(+2.7%) | $3.69B(+0.1%) |
Jun 2020 | - | $861.00M(-6.1%) | $3.68B(-2.7%) |
Mar 2020 | - | $917.00M(-10.5%) | $3.78B(-0.6%) |
Dec 2019 | $3.81B(-9.7%) | $1.02B(+16.5%) | $3.81B(-3.0%) |
Sep 2019 | - | $880.00M(-8.5%) | $3.92B(-3.2%) |
Jun 2019 | - | $962.00M(+2.3%) | $4.05B(-0.9%) |
Mar 2019 | - | $940.00M(-17.6%) | $4.09B(-3.0%) |
Dec 2018 | $4.21B(-13.0%) | $1.14B(+13.2%) | $4.21B(+3.5%) |
Sep 2018 | - | $1.01B(+1.0%) | $4.07B(-4.8%) |
Jun 2018 | - | $998.00M(-6.5%) | $4.28B(-6.7%) |
Mar 2018 | - | $1.07B(+6.7%) | $4.59B(-5.3%) |
Dec 2017 | $4.85B(-2.6%) | $1.00B(-17.7%) | $4.85B(-6.1%) |
Sep 2017 | - | $1.22B(-7.0%) | $5.16B(-0.7%) |
Jun 2017 | - | $1.31B(-1.3%) | $5.20B(+0.9%) |
Mar 2017 | - | $1.32B(+0.5%) | $5.15B(+3.6%) |
Dec 2016 | $4.97B(+2.8%) | $1.32B(+5.4%) | $4.97B(-0.2%) |
Sep 2016 | - | $1.25B(-1.0%) | $4.98B(+3.2%) |
Jun 2016 | - | $1.26B(+10.5%) | $4.83B(+1.6%) |
Mar 2016 | - | $1.14B(-13.9%) | $4.75B(-1.8%) |
Dec 2015 | $4.84B(-4.7%) | $1.33B(+21.2%) | $4.84B(+0.0%) |
Sep 2015 | - | $1.10B(-7.5%) | $4.84B(-3.0%) |
Jun 2015 | - | $1.19B(-3.6%) | $4.98B(-0.8%) |
Mar 2015 | - | $1.23B(-7.3%) | $5.02B(-1.1%) |
Dec 2014 | $5.08B(-4.5%) | $1.33B(+6.7%) | $5.08B(-2.3%) |
Sep 2014 | - | $1.24B(+1.6%) | $5.20B(-0.5%) |
Jun 2014 | - | $1.22B(-4.9%) | $5.22B(-1.5%) |
Mar 2014 | - | $1.29B(-11.2%) | $5.30B(-0.3%) |
Dec 2013 | $5.32B(+3.9%) | $1.45B(+14.2%) | $5.32B(+1.4%) |
Sep 2013 | - | $1.27B(-2.5%) | $5.25B(+1.2%) |
Jun 2013 | - | $1.30B(-0.1%) | $5.18B(+0.1%) |
Mar 2013 | - | $1.30B(-5.2%) | $5.18B(+1.2%) |
Dec 2012 | $5.12B(+16.0%) | $1.37B(+13.9%) | $5.12B(+0.5%) |
Sep 2012 | - | $1.21B(-7.0%) | $5.09B(+6.0%) |
Jun 2012 | - | $1.30B(+4.6%) | $4.81B(+4.5%) |
Mar 2012 | - | $1.24B(-8.2%) | $4.60B(+4.2%) |
Dec 2011 | $4.41B(+15.1%) | $1.35B(+47.2%) | $4.41B(+6.6%) |
Sep 2011 | - | $918.00M(-15.6%) | $4.14B(-1.6%) |
Jun 2011 | - | $1.09B(+3.3%) | $4.21B(+6.5%) |
Mar 2011 | - | $1.05B(-2.4%) | $3.95B(+3.1%) |
Dec 2010 | $3.83B | $1.08B(+9.3%) | $3.83B(+2.9%) |
Sep 2010 | - | $987.00M(+18.5%) | $3.72B(+2.9%) |
Jun 2010 | - | $833.00M(-10.8%) | $3.62B(-0.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2010 | - | $934.00M(-3.7%) | $3.63B(+3.8%) |
Dec 2009 | $3.50B(+39.3%) | $970.00M(+9.9%) | $3.50B(+9.0%) |
Sep 2009 | - | $883.00M(+4.4%) | $3.21B(+7.9%) |
Jun 2009 | - | $846.00M(+5.8%) | $2.97B(+6.3%) |
Mar 2009 | - | $800.00M(+17.6%) | $2.80B(+11.4%) |
Dec 2008 | $2.51B(+32.1%) | $680.00M(+4.9%) | $2.51B(+6.9%) |
Sep 2008 | - | $648.00M(-3.1%) | $2.35B(+8.8%) |
Jun 2008 | - | $669.00M(+30.2%) | $2.16B(+10.2%) |
Mar 2008 | - | $514.00M(-0.8%) | $1.96B(+3.1%) |
Dec 2007 | $1.90B(+20.9%) | $518.00M(+13.1%) | $1.90B(+2.2%) |
Sep 2007 | - | $458.00M(-2.3%) | $1.86B(+3.0%) |
Jun 2007 | - | $469.00M(+2.9%) | $1.81B(+5.5%) |
Mar 2007 | - | $456.00M(-4.4%) | $1.71B(+8.9%) |
Dec 2006 | $1.57B(+96.7%) | $477.10M(+18.2%) | $1.57B(+19.8%) |
Sep 2006 | - | $403.80M(+7.5%) | $1.31B(+16.9%) |
Jun 2006 | - | $375.50M(+18.8%) | $1.12B(+20.7%) |
Mar 2006 | - | $316.00M(+45.2%) | $930.40M(+16.4%) |
Dec 2005 | $799.00M(+14.6%) | $217.70M(+1.7%) | $799.00M(+3.8%) |
Sep 2005 | - | $214.00M(+17.1%) | $769.70M(+4.4%) |
Jun 2005 | - | $182.70M(-1.0%) | $737.20M(+1.9%) |
Mar 2005 | - | $184.60M(-2.0%) | $723.50M(+3.8%) |
Dec 2004 | $697.00M(+33.9%) | $188.40M(+3.8%) | $697.00M(+7.0%) |
Sep 2004 | - | $181.50M(+7.4%) | $651.30M(+9.4%) |
Jun 2004 | - | $169.00M(+6.9%) | $595.10M(+7.0%) |
Mar 2004 | - | $158.10M(+10.8%) | $556.00M(+6.8%) |
Dec 2003 | $520.60M(+28.1%) | $142.70M(+13.9%) | $520.60M(+8.0%) |
Sep 2003 | - | $125.30M(-3.5%) | $482.00M(+3.6%) |
Jun 2003 | - | $129.90M(+5.9%) | $465.10M(+7.2%) |
Mar 2003 | - | $122.70M(+17.9%) | $433.90M(+6.8%) |
Dec 2002 | $406.40M(+11.8%) | $104.10M(-4.0%) | $406.40M(+1.4%) |
Sep 2002 | - | $108.40M(+9.8%) | $400.86M(+6.4%) |
Jun 2002 | - | $98.70M(+3.7%) | $376.66M(+2.1%) |
Mar 2002 | - | $95.20M(-3.4%) | $368.74M(+1.4%) |
Dec 2001 | $363.56M(+18.4%) | $98.56M(+17.1%) | $363.60M(+1.3%) |
Sep 2001 | - | $84.20M(-7.2%) | $359.04M(+1.7%) |
Jun 2001 | - | $90.78M(+0.8%) | $353.11M(+5.3%) |
Mar 2001 | - | $90.06M(-4.2%) | $335.48M(+9.2%) |
Dec 2000 | $307.08M(+31.3%) | $94.00M(+20.1%) | $307.08M(+8.8%) |
Sep 2000 | - | $78.27M(+7.0%) | $282.27M(+8.1%) |
Jun 2000 | - | $73.14M(+18.6%) | $261.20M(+7.6%) |
Mar 2000 | - | $61.66M(-10.9%) | $242.85M(+3.8%) |
Dec 1999 | $233.89M(+12.4%) | $69.19M(+21.0%) | $233.89M(+6.4%) |
Sep 1999 | - | $57.20M(+4.4%) | $219.80M(-0.0%) |
Jun 1999 | - | $54.80M(+4.0%) | $219.90M(+2.8%) |
Mar 1999 | - | $52.70M(-4.4%) | $214.00M(+2.8%) |
Dec 1998 | $208.00M(+5.6%) | $55.10M(-3.8%) | $208.10M(+36.0%) |
Sep 1998 | - | $57.30M(+17.2%) | $153.00M(+59.9%) |
Jun 1998 | - | $48.90M(+4.5%) | $95.70M(+104.5%) |
Mar 1998 | - | $46.80M | $46.80M |
Dec 1997 | $197.00M(+17.5%) | - | - |
Dec 1996 | $167.60M(+15.3%) | - | - |
Dec 1995 | $145.40M(+12.1%) | - | - |
Dec 1994 | $129.70M(+28.2%) | - | - |
Dec 1993 | $101.20M(+22.7%) | - | - |
Dec 1992 | $82.50M(+23.0%) | - | - |
Dec 1991 | $67.10M(-20.9%) | - | - |
Dec 1990 | $84.80M(+51.2%) | - | - |
Dec 1989 | $56.10M(+9.4%) | - | - |
Dec 1988 | $51.30M(+69.3%) | - | - |
Mar 1987 | $30.30M(+78.2%) | - | - |
Mar 1986 | $17.00M | - | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual SGA?
- What is the all time high annual SGA for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual SGA year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly SGA?
- What is the all time high quarterly SGA for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly SGA year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM SGA?
- What is the all time high TTM SGA for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM SGA year-on-year change?
What is Teva Pharmaceutical Industries Limited annual SGA?
The current annual SGA of TEVA is $3.70B
What is the all time high annual SGA for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual SGA is $5.32B
What is Teva Pharmaceutical Industries Limited annual SGA year-on-year change?
Over the past year, TEVA annual SGA has changed by +$204.00M (+5.83%)
What is Teva Pharmaceutical Industries Limited quarterly SGA?
The current quarterly SGA of TEVA is $919.00M
What is the all time high quarterly SGA for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly SGA is $1.45B
What is Teva Pharmaceutical Industries Limited quarterly SGA year-on-year change?
Over the past year, TEVA quarterly SGA has changed by +$33.00M (+3.72%)
What is Teva Pharmaceutical Industries Limited TTM SGA?
The current TTM SGA of TEVA is -$59.61B
What is the all time high TTM SGA for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM SGA is $59.94B
What is Teva Pharmaceutical Industries Limited TTM SGA year-on-year change?
Over the past year, TEVA TTM SGA has changed by -$63.15B (-1782.83%)